AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
+31.28%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$62.3M
AUM Growth
+$62.3M
(+22%)
Cap. Flow
-$97.9M
Cap. Flow
% of AUM
-157.1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
American Well
AMWL
|
$94.3M |
| 2 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$3.36M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$205K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Annexon
ANNX
$226M
| $43.8M | 70.35% |
7,406,024
| – | – |
|
2
Akebia Therapeutics
AKBA
$833M
| $7.59M | 12.17% |
5,747,906
| – | – |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $5.92M | 9.5% |
205,880
-7,120
| -3% | -$205K |
|
|
4
American Well
AMWL
$111M
| $4.97M | 7.97% |
523,785
-9,951,932
| -95% | -$94.3M |
|
|
WHWK
5
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $1.36K | ﹤0.01% |
659
-1,630,171
| -100% | -$3.36M |
|